Literature DB >> 30761582

Blood pressure variability and hemorrhagic transformation in patients with successful recanalization after endovascular recanalization therapy: A retrospective observational study.

Tae Jung Kim1, Hee-Kwon Park2, Jeong-Min Kim3, Ji Sung Lee4, Soo-Hyun Park1, Hae-Bong Jeong1, Kwang-Yeol Park3, Joung-Ho Rha2, Byung-Woo Yoon1, Sang-Bae Ko1.   

Abstract

OBJECTIVE: Although blood pressure (BP) variability has been regarded as a risk factor for hemorrhagic transformation (HTF) after intravenous thrombolysis, its effect on HTF after endovascular recanalization therapy (ERT) remains to be elucidated. We aimed to study the relationship between BP variability and symptomatic intracerebral hemorrhage (sICH) after successful recanalization with ERT.
METHODS: A total of 211 patients with acute ischemic stroke and successful recanalization (thrombolysis in cerebral infarction 2b or 3) after ERT were included between January 2013 and May 2017. The BP data following ERT was obtained over the first 24 hours using parameters including mean, maximum, minimum, difference between maximum and minimum, standard deviation, coefficient of variation, successive variations, and time rate (TR) of BP variation for systolic BP (SBP) and diastolic BP. sICH was defined as parenchymal hemorrhage type 2 with neurological deterioration of 4 points of more on the National Institute of Health Stroke Scale.
RESULTS: Among the included patients, 20 (9.5%) developed sICH after successful ERT. The parameters linked with BP fluctuation over time were significantly related to sICH. After adjusting for confounders, the TR of SBP (per 0.1 mmHg/min increase) variation was independently associated with sICH (odds ratio = 1.71, 95% confidence interval = 1.013-2.886).
INTERPRETATION: Time-related BP variability in the first 24 hours following successful ERT was more correlated with sICH than other absolute BP levels. This suggests that maintaining a stable BP may be an important factor in preventing sICH after successful ERT. Ann Neurol 2019;85:574-581.
© 2019 American Neurological Association.

Entities:  

Mesh:

Year:  2019        PMID: 30761582     DOI: 10.1002/ana.25434

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  22 in total

1.  Fixed Compared With Autoregulation-Oriented Blood Pressure Thresholds After Mechanical Thrombectomy for Ischemic Stroke.

Authors:  Nils H Petersen; Andrew Silverman; Sumita M Strander; Sreeja Kodali; Anson Wang; Lauren H Sansing; Joseph L Schindler; Guido J Falcone; Emily J Gilmore; Adam S Jasne; Branden Cord; Ryan M Hebert; Michele Johnson; Charles C Matouk; Kevin N Sheth
Journal:  Stroke       Date:  2020-02-12       Impact factor: 7.914

2.  Association of Blood Pressure With Outcomes in Acute Stroke Thrombectomy.

Authors:  Konark Malhotra; Nitin Goyal; Aristeidis H Katsanos; Angeliki Filippatou; Eva A Mistry; Pooja Khatri; Mohammad Anadani; Alejandro M Spiotta; Else Charlotte Sandset; Amrou Sarraj; Georgios Magoufis; Christos Krogias; Lars Tönges; Apostolos Safouris; Lucas Elijovich; Mayank Goyal; Adam Arthur; Andrei V Alexandrov; Georgios Tsivgoulis
Journal:  Hypertension       Date:  2020-01-13       Impact factor: 10.190

3.  Blood Pressure Variability and Neurologic Outcome After Endovascular Thrombectomy: A Secondary Analysis of the BEST Study.

Authors:  Eva A Mistry; Tapan Mehta; Akshitkumar Mistry; Niraj Arora; Amy K Starosciak; Felipe De Los Rios La Rosa; James Ernest Siegler; Rohan Chitale; Mohammad Anadani; Shadi Yaghi; Pooja Khatri; Adam de Havenon
Journal:  Stroke       Date:  2019-12-09       Impact factor: 7.914

Review 4.  Hemorrhagic Transformation After Tissue Plasminogen Activator Treatment in Acute Ischemic Stroke.

Authors:  Chengli Liu; Jie Xie; Shanshan Sun; Hui Li; Tianyu Li; Chao Jiang; Xuemei Chen; Junmin Wang; Anh Le; Jiarui Wang; Zhanfei Li; Jian Wang; Wei Wang
Journal:  Cell Mol Neurobiol       Date:  2020-10-30       Impact factor: 5.046

5.  Short-term glycemic variability and hemorrhagic transformation after successful endovascular thrombectomy.

Authors:  Tae Jung Kim; Ji Sung Lee; Soo-Hyun Park; Sang-Bae Ko
Journal:  Transl Stroke Res       Date:  2021-02-12       Impact factor: 6.829

6.  Adverse Outcomes Associated With Higher Mean Blood Pressure and Greater Blood Pressure Variability Immediately After Successful Embolectomy in Those With Acute Ischemic Stroke, and the Influence of Pretreatment Collateral Circulation Status.

Authors:  Dacheng Liu; Ximing Nie; Yuesong Pan; Hongyi Yan; Yuehua Pu; Yufei Wei; Yuan Cai; Yarong Ding; Qixuan Lu; Zhe Zhang; Weibin Gu; Xinyi Hou; Zhonghua Yang; Miao Wen; Penglian Wang; Gaoting Ma; Ning Ma; Zhongrong Miao; Xinyi Leng; Bernard Yan; Stephen M Davis; Yongjun Wang; Liping Liu
Journal:  J Am Heart Assoc       Date:  2021-02-26       Impact factor: 5.501

7.  Systemic arterial blood pressure and intracerebral hemorrhage after mechanical thrombectomy in anterior cerebral circulation.

Authors:  Jiaqi An; Yonglan Tang; Xiangqi Cao; Huijie Yuan; Meng Wei; Xingyun Yuan; Aifeng Zhang; Yongxin Li; Ardan Saguner; Guoliang Li; Guogang Luo
Journal:  J Investig Med       Date:  2021-03-02       Impact factor: 2.895

Review 8.  Intracranial Bleeding After Reperfusion Therapy in Acute Ischemic Stroke.

Authors:  Guillaume Charbonnier; Louise Bonnet; Alessandra Biondi; Thierry Moulin
Journal:  Front Neurol       Date:  2021-02-09       Impact factor: 4.003

9.  Time Course and Clinical Relevance of Neurological Deterioration After Endovascular Recanalization Therapy for Anterior Circulation Large Vessel Occlusion Stroke.

Authors:  Zibao Li; Hongchuan Zhang; Jian Han; Zhaohu Chu; Shoucai Zhao; Qian Yang; Xianjun Huang; Zhiming Zhou
Journal:  Front Aging Neurosci       Date:  2021-06-29       Impact factor: 5.750

10.  Rapid Assessment of Blood Pressure Variability and Outcome After Successful Thrombectomy.

Authors:  Pedro Castro; Francisca Ferreira; Cindy K Nguyen; Seyedmehdi Payabvash; Can Ozan Tan; Farzaneh Sorond; Elsa Azevedo; Nils Petersen
Journal:  Stroke       Date:  2021-07-27       Impact factor: 10.170

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.